Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain

NCT06053242 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Low-back Pain
Degenerative Disc Disease

Interventions

DRUG: CELZ-201-DDT
OTHER: Placebo

Sponsor

Creative Medical Technology Holdings Inc